HYC(688001)2022-10-30 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥566,515,438.68, a decrease of 3.07% compared to the same period last year[6]. - The net profit attributable to shareholders for Q3 2022 was ¥133,285,855.81, an increase of 2.54% year-on-year[6]. - The net profit after deducting non-recurring gains and losses was ¥126,988,824.27, reflecting a 3.72% increase compared to the same period last year[9]. - Total operating revenue for the first three quarters of 2022 reached ¥1,668,510,321.38, an increase of 16.7% compared to ¥1,429,876,382.64 in the same period of 2021[42]. - Net profit for the third quarter of 2022 was ¥304,762,898.19, compared to ¥270,895,137.03 in the previous year, marking an increase of 12.5%[44]. Assets and Liabilities - The total assets at the end of Q3 2022 amounted to ¥5,382,014,033.73, representing a 4.50% increase from the end of the previous year[9]. - The total assets of the company increased to ¥5,382,014,033.73 from ¥5,150,193,613.80, representing a growth of 4.5%[42]. - The company's total liabilities decreased slightly to ¥1,607,371,108.41 from ¥1,618,455,597.93, a decline of 0.5%[39]. - The equity attributable to shareholders rose to ¥3,774,642,925.32 from ¥3,531,738,015.87, an increase of 6.9%[39]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥15,695,275.15, showing a significant decrease of 37.19% compared to the same period last year[9]. - The total cash inflow from operating activities was CNY 1,645,158,972.63, compared to CNY 1,335,119,095.06 in the previous year, marking an increase of approximately 23.2%[50]. - The net cash flow from financing activities was negative at CNY -109,571,490.83, compared to a positive CNY 1,596,285.49 in the same period last year[52]. - The company's cash and cash equivalents at the end of the period amounted to CNY 1,179,437,777.81, up from CNY 789,601,968.29 at the end of the previous year[52]. Research and Development - Research and development expenses totaled ¥102,037,758.80, accounting for 18.01% of operating revenue, which is an increase of 1.30 percentage points year-on-year[9]. - Research and development expenses amounted to ¥276,670,013.42, up from ¥238,429,328.69, indicating a rise of 16%[42]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,563, with the largest shareholder holding 52.42% of the shares[22]. - The top ten shareholders include Suzhou Yuanhua Chuangxing Investment Management Co., Ltd., holding 230,976,000 shares, accounting for 52.42%[22]. Other Financial Metrics - The basic earnings per share for Q3 2022 was ¥0.30, while diluted earnings per share was ¥0.29, a decrease of 3.33% compared to the previous quarter[9]. - The weighted average return on equity was 3.53%, a decrease of 0.49 percentage points compared to the previous year[9]. - The company reported a financial expense of -¥58,786,514.71, compared to -¥10,559,487.01 in the previous year, indicating a significant increase in financial costs[42]. - The total comprehensive income for the period attributable to the parent company reached CNY 307,448,665.43, an increase from CNY 269,292,500.47 in the previous year, representing a growth of approximately 14.5%[47]. - Basic earnings per share increased to CNY 0.69 from CNY 0.62, reflecting a growth of about 11.3% year-over-year[47]. Inventory and Impairment - Inventory as of September 30, 2022, was 599,230,318.64, up from 494,746,022.14 in the previous year[33]. - The company reported an asset impairment loss of 138.21 million, primarily due to inventory write-downs[21]. Government Subsidies and Other Gains - The company reported a government subsidy of ¥2,443,481.36 recognized in the current period, contributing to non-recurring gains[9]. - The company experienced a foreign exchange gain of CNY 56,251,712.49, compared to CNY 1,022,037.92 in the previous year, indicating a significant increase in foreign exchange impact[52]. Cash Flow from Investments - Cash inflow from investment activities totaled CNY 2,593,405,909.07, significantly higher than CNY 1,433,843,712.14 in the previous year, indicating a growth of approximately 81%[50]. - The company reported a significant increase in cash received from investment recoveries, totaling CNY 2,566,900,500.00, compared to CNY 1,415,954,575.04 in the previous year, representing an increase of about 81.2%[50].